Cargando…
The efficacy of antipsychotics for prolonged delirium with renal dysfunction
AIM: Delirium is commonly encountered in daily clinical practice. To identify predictors influencing outcomes, we retrospectively examined the characteristics of inpatients with delirium who required psychiatric medication during hospitalization. METHODS: We extracted all new inpatients (n=523) cons...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695253/ https://www.ncbi.nlm.nih.gov/pubmed/29180868 http://dx.doi.org/10.2147/NDT.S147701 |
_version_ | 1783280278633971712 |
---|---|
author | Asano, Satoko Kunii, Yasuto Hoshino, Hiroshi Osakabe, Yusuke Shiga, Tetsuya Itagaki, Shuntaro Miura, Itaru Yabe, Hirooki |
author_facet | Asano, Satoko Kunii, Yasuto Hoshino, Hiroshi Osakabe, Yusuke Shiga, Tetsuya Itagaki, Shuntaro Miura, Itaru Yabe, Hirooki |
author_sort | Asano, Satoko |
collection | PubMed |
description | AIM: Delirium is commonly encountered in daily clinical practice. To identify predictors influencing outcomes, we retrospectively examined the characteristics of inpatients with delirium who required psychiatric medication during hospitalization. METHODS: We extracted all new inpatients (n=523) consulted for psychiatric symptoms at Fukushima Medical University Hospital between October 2011 and September 2013. We selected 203 inpatients with delirium diagnosed by psychiatrists. We analyzed data from 177 inpatients with delirium who received psychiatric medication. We defined an “early improvement group” in which delirium resolved in ≤3 days after starting psychiatric medication, and a “prolonged group” with delirium lasting for >3 days. Among the 83 inpatients with renal dysfunction (estimated glomerular filtration rate <60 mL/min/1.73 m(2)), we defined an “early improvement group with renal dysfunction” in which delirium resolved in ≤3 days after starting psychiatric medication and a “prolonged group with renal dysfunction” with delirium lasting for >3 days. We then examined differences between groups for different categorical variables. RESULTS: Dose of antipsychotic medication at end point was significantly lower in the prolonged group with renal dysfunction than in the early improvement group with renal dysfunction. CONCLUSION: The results suggest that maintaining a sufficient dose of antipsychotics from an early stage may prevent prolongation of delirium even in inpatients with renal dysfunction. |
format | Online Article Text |
id | pubmed-5695253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56952532017-11-27 The efficacy of antipsychotics for prolonged delirium with renal dysfunction Asano, Satoko Kunii, Yasuto Hoshino, Hiroshi Osakabe, Yusuke Shiga, Tetsuya Itagaki, Shuntaro Miura, Itaru Yabe, Hirooki Neuropsychiatr Dis Treat Original Research AIM: Delirium is commonly encountered in daily clinical practice. To identify predictors influencing outcomes, we retrospectively examined the characteristics of inpatients with delirium who required psychiatric medication during hospitalization. METHODS: We extracted all new inpatients (n=523) consulted for psychiatric symptoms at Fukushima Medical University Hospital between October 2011 and September 2013. We selected 203 inpatients with delirium diagnosed by psychiatrists. We analyzed data from 177 inpatients with delirium who received psychiatric medication. We defined an “early improvement group” in which delirium resolved in ≤3 days after starting psychiatric medication, and a “prolonged group” with delirium lasting for >3 days. Among the 83 inpatients with renal dysfunction (estimated glomerular filtration rate <60 mL/min/1.73 m(2)), we defined an “early improvement group with renal dysfunction” in which delirium resolved in ≤3 days after starting psychiatric medication and a “prolonged group with renal dysfunction” with delirium lasting for >3 days. We then examined differences between groups for different categorical variables. RESULTS: Dose of antipsychotic medication at end point was significantly lower in the prolonged group with renal dysfunction than in the early improvement group with renal dysfunction. CONCLUSION: The results suggest that maintaining a sufficient dose of antipsychotics from an early stage may prevent prolongation of delirium even in inpatients with renal dysfunction. Dove Medical Press 2017-11-16 /pmc/articles/PMC5695253/ /pubmed/29180868 http://dx.doi.org/10.2147/NDT.S147701 Text en © 2017 Asano et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Asano, Satoko Kunii, Yasuto Hoshino, Hiroshi Osakabe, Yusuke Shiga, Tetsuya Itagaki, Shuntaro Miura, Itaru Yabe, Hirooki The efficacy of antipsychotics for prolonged delirium with renal dysfunction |
title | The efficacy of antipsychotics for prolonged delirium with renal dysfunction |
title_full | The efficacy of antipsychotics for prolonged delirium with renal dysfunction |
title_fullStr | The efficacy of antipsychotics for prolonged delirium with renal dysfunction |
title_full_unstemmed | The efficacy of antipsychotics for prolonged delirium with renal dysfunction |
title_short | The efficacy of antipsychotics for prolonged delirium with renal dysfunction |
title_sort | efficacy of antipsychotics for prolonged delirium with renal dysfunction |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695253/ https://www.ncbi.nlm.nih.gov/pubmed/29180868 http://dx.doi.org/10.2147/NDT.S147701 |
work_keys_str_mv | AT asanosatoko theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT kuniiyasuto theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT hoshinohiroshi theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT osakabeyusuke theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT shigatetsuya theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT itagakishuntaro theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT miuraitaru theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT yabehirooki theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT asanosatoko efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT kuniiyasuto efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT hoshinohiroshi efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT osakabeyusuke efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT shigatetsuya efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT itagakishuntaro efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT miuraitaru efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction AT yabehirooki efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction |